UPDATE 1-Teva Pharm raises full-year profit forecast after solid second quarter
July 31, 2014 at 10:16 AM EDT
* Now sees 2014 EPS $4.50-$4.80 with Copaxone competition
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.